Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy

Diabetic nephropathy (DN) together with glomerular hyperfiltration has been implicated in the development of diabetic microangiopathy in the initial stage of diabetic diseases. Increased amounts of urinary protein in DN may be associated with functional and morphological alterations of podocyte, mainly including podocyte hypertrophy, epithelial-mesenchymal transdifferentiation (EMT), podocyte detachment, and podocyte apoptosis. Accumulating studies have revealed that disruption in multiple renal signaling pathways had been critical in the progression of these pathological damages, such as adenosine monophosphate-activated kinase signaling pathways (AMPK), wnt/β-catenin signaling pathways, endoplasmic reticulum stress-related signaling pathways, mammalian target of rapamycin (mTOR)/autophagy pathway, and Rho GTPases. In this review, we highlight new molecular insights underlying podocyte injury in the progression of DN, which offer new therapeutic targets to develop important renoprotective treatments for DN over the next decade.

[1]  Y. Tomino,et al.  Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice. , 2015, Biochemical and biophysical research communications.

[2]  G. Crepaldi,et al.  Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. , 2003, Diabetes.

[3]  Shyi-Jang Shin,et al.  Altering expression of α3β1 integrin on podocytes of human and rats with diabetes , 2000 .

[4]  Jinghong Zhao,et al.  Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice , 2014, Molecular and Cellular Biochemistry.

[5]  Peiqing Liu,et al.  Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling , 2013, Molecular and Cellular Endocrinology.

[6]  K. Ma,et al.  Effects of Angiotensin Receptor Blocker on Phenotypic Alterations of Podocytes in Early Diabetic Nephropathy , 2011, The American journal of the medical sciences.

[7]  Mary E. Choi,et al.  Autophagy in diabetic nephropathy. , 2014, The Journal of endocrinology.

[8]  Phillip Ruiz,et al.  Mechanisms of the proteinuria induced by Rho GTPases , 2012, Kidney international.

[9]  Merlin C. Thomas,et al.  Nutrient Sensing, Autophagy, and Diabetic Nephropathy , 2011, Diabetes.

[10]  K. Yokote,et al.  Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes , 2014, Journal of diabetes investigation.

[11]  F. Brosius,et al.  Abnormalities in signaling pathways in diabetic nephropathy , 2010, Expert review of endocrinology & metabolism.

[12]  L. Truong,et al.  Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy , 2015, The Journal of pathology.

[13]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[14]  Mayuko F Kato,et al.  Hypertrophy and loss of podocytes in diabetic nephropathy. , 2009, Internal medicine.

[15]  T. Ogihara,et al.  Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats , 2007, Laboratory Investigation.

[16]  Yi-Pu Chen,et al.  The Protective Effects of Curcumin on Obesity-Related Glomerulopathy Are Associated with Inhibition of Wnt/β-Catenin Signaling Activation in Podocytes , 2015, Evidence-based complementary and alternative medicine : eCAM.

[17]  Nam-Ho Kim.  Podocyte hypertrophy in diabetic nephropathy , 2005, Nephrology.

[18]  C. Cohen,et al.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. , 2010, The Journal of clinical investigation.

[19]  K. Lemley,et al.  Urinary excretion of viable podocytes in health and renal disease. , 2003, American journal of physiology. Renal physiology.

[20]  R. Wanke,et al.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. , 2011, The Journal of clinical investigation.

[21]  Dingkun Gui,et al.  Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via alpha3beta1 integrin upregulation and integrin-linked kinase inhibition. , 2008, Biochemical pharmacology.

[22]  L. Holzman,et al.  Clinical impact of research on the podocyte slit diaphragm , 2006, Nature Clinical Practice Nephrology.

[23]  Ting-ting Guo,et al.  Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress , 2015, Journal of Physiology and Biochemistry.

[24]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[25]  Xiwu Chen,et al.  Integrins in renal development , 2012, Pediatric Nephrology.

[26]  Shuxia Liu,et al.  PTEN Inhibits High Glucose‐Induced Phenotypic Transition in Podocytes , 2015, Journal of cellular biochemistry.

[27]  Xiaomei Wu,et al.  Improving the Measurement of Semantic Similarity between Gene Ontology Terms and Gene Products: Insights from an Edge- and IC-Based Hybrid Method , 2013, PloS one.

[28]  Y. Kim,et al.  The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy , 2016, Kidney research and clinical practice.

[29]  S. Wesselborg,et al.  Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.

[30]  Yu Sun,et al.  The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes. , 2013, Cellular signalling.

[31]  M. Mauer,et al.  The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. , 2002, Diabetes.

[32]  P. López-Luna,et al.  Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  L. Gnudi,et al.  Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms , 2016, Trends in Endocrinology & Metabolism.

[34]  K. Suszták,et al.  Podocytes: the Weakest Link in Diabetic Kidney Disease? , 2016, Current Diabetes Reports.

[35]  K. Kimura,et al.  Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  Lingling Wu,et al.  Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury , 2013, PloS one.

[37]  K. Chorneyko,et al.  RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease , 2008, Diabetes.

[38]  K. Suszták,et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease , 2008, Nature Medicine.

[39]  Yasuhiko Tomino,et al.  Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling , 2006, Nature Cell Biology.

[40]  G. Wolf,et al.  Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? , 2015, Cells.

[41]  M. Taketo,et al.  Wnt/β-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival* , 2011, The Journal of Biological Chemistry.

[42]  J. Forbes,et al.  Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy? , 2014, The Journal of endocrinology.

[43]  T. Meyer,et al.  Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.

[44]  D. H. Kim,et al.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes , 2012, Diabetologia.

[45]  Jun Yang,et al.  Effect of Taurine-Conjugated Ursodeoxycholic Acid on Endoplasmic Reticulum Stress and Apoptosis Induced by Advanced Glycation End Products in Cultured Mouse Podocytes , 2008, American Journal of Nephrology.

[46]  E. Wolf,et al.  Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. , 2009, American journal of physiology. Renal physiology.

[47]  Hani Suleiman,et al.  Rac1 Activation in Podocytes Induces Rapid Foot Process Effacement and Proteinuria , 2013, Molecular and Cellular Biology.

[48]  H. Abboud,et al.  Mechanisms of Podocyte Injury in Diabetes , 2009, Diabetes.

[49]  Yaeni Kim,et al.  Adenosine monophosphate–activated protein kinase in diabetic nephropathy , 2016, Kidney research and clinical practice.

[50]  B. Falkner,et al.  Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.

[51]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[52]  J. Xu,et al.  Wnt/β‐catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes , 2013, Cell proliferation.

[53]  Shuxia Liu,et al.  Nestin protects mouse podocytes against high glucose‐induced apoptosis by a Cdk5‐dependent mechanism , 2012, Journal of cellular biochemistry.

[54]  K. Utsunomiya,et al.  Signaling pathways in diabetic nephropathy. , 2016, Histology and histopathology.

[55]  J. He,et al.  Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study , 2012, PloS one.

[56]  L. Truong,et al.  Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease , 2004 .

[57]  B. Zhang,et al.  The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury , 2015, Laboratory Investigation.

[58]  M. Regoli,et al.  Alterations in the expression of the a3b1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus , 1997, Diabetologia.

[59]  K. Isshiki,et al.  Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. , 2006, Biochemical and biophysical research communications.

[60]  F. Gao,et al.  Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway. , 2016, International journal of molecular medicine.

[61]  R. Waldherr,et al.  Structural Analysis of How Podocytes Detach from the Glomerular Basement Membrane Under Hypertrophic Stress , 2014, Front. Endocrinol..

[62]  J. Uribarri,et al.  Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. , 2007, Kidney international.

[63]  Youhua Liu,et al.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. , 2008, The American journal of pathology.

[64]  D. Lacombe,et al.  High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  K. Guan,et al.  mTOR in podocyte function , 2011, Cell cycle.

[66]  A. Fornoni,et al.  Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. , 2008, Kidney international.

[67]  Katalin Susztak,et al.  Notch signaling in diabetic nephropathy. , 2012, Experimental cell research.

[68]  S. Shankland,et al.  Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. , 2005, Journal of the American Society of Nephrology : JASN.

[69]  S. Levy,et al.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. , 2013, The Journal of clinical investigation.

[70]  Hai-Bo Long,et al.  Metadherin facilitates podocyte apoptosis in diabetic nephropathy , 2016, Cell Death and Disease.

[71]  L. Truong,et al.  Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  H. Shafi,et al.  Histological changes of kidney in diabetic nephropathy , 2015, Caspian journal of internal medicine.

[73]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[74]  Yu Sun,et al.  NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis. , 2015, Molecular medicine reports.

[75]  Niansong Wang,et al.  Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. , 2013, Cytokine.

[76]  Xiao-Jun Ji,et al.  Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. , 2015, Pharmacological research.

[77]  Hui Yu,et al.  Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6. , 2016, Molecular medicine reports.

[78]  M. Hall,et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. , 2011, The Journal of clinical investigation.

[79]  R. Komers.  Rho kinase inhibition in diabetic kidney disease , 2013, British journal of clinical pharmacology.

[80]  L. Gan,et al.  Adiponectin reduces ER stress-induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose , 2016, Cell Death and Disease.

[81]  Marlies Sachs,et al.  The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation. , 2013, Kidney international.

[82]  Hernan Rincon-Choles,et al.  Redox dependence of glomerular epithelial cell hypertrophy in response to glucose. , 2006, American journal of physiology. Renal physiology.

[83]  F. Gao,et al.  Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose , 2014, International journal of molecular medicine.

[84]  J. Xu,et al.  Effect of BMP7 on podocyte transdifferentiation and Smad7 expression induced by hyperglycemia. , 2015, Clinical Nephrology.

[85]  T. Uzu,et al.  Autophagy as a Therapeutic Target in Diabetic Nephropathy , 2011, Experimental diabetes research.

[86]  Chinfei Chen,et al.  Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. , 2000, Life sciences.

[87]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[88]  Yonghong Sun,et al.  Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy , 2016, International journal of molecular sciences.

[89]  J. Guan,et al.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.

[90]  Lin Sun,et al.  A Glimpse of the Pathogenetic Mechanisms of Wnt/β-Catenin Signaling in Diabetic Nephropathy , 2013, BioMed research international.

[91]  R. Austin,et al.  Endoplasmic reticulum stress and lipid dysregulation , 2011, Expert Reviews in Molecular Medicine.

[92]  P. Overbeek,et al.  Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. , 2012, Cell metabolism.

[93]  T. Takeda.  Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and ezrin , 2003, Journal of Clinical and Experimental Nephrology.

[94]  Youhua Liu,et al.  Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[95]  Matthias Kretzler,et al.  Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury , 2013, Kidney international.

[96]  C. Kahn,et al.  Insulin signaling to the glomerular podocyte is critical for normal kidney function. , 2010, Cell metabolism.